Spruce Biosciences
(NASDAQ) SPRB
Spruce Biosciences Financials at a Glance
Market Cap
$81.01M
Revenue (TTM)
$0.00
Net Income (TTM)
$38.97M
EPS (TTM)
$-52.72
P/E Ratio
-1.12
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Price
$56.09
Volume
734
Open
$59.53
Price
$56.09
Volume
734
Open
$59.53
Previous Close
$59.05
Daily Range
$56.09 - $62.12
52-Week Range
$4.28 - $240.00
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Price
$56.09
Volume
734
Open
$59.53
Previous Close
$59.05
Daily Range
$56.09 - $62.12
52-Week Range
$4.28 - $240.00
SPRB News
SPRB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Spruce Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Javier Szwarcberg, MD
Website
sprucebio.comHeadquarters
Daly City, CA 94014, US
SPRB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-109%
Return on Capital
-85%
Return on Assets
-73%
Earnings Yield
-89.29%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$81.01M
Shares Outstanding
1.37M
Volume
734
Short Interest
0.00%
Avg. Volume
37.48K
Financials (TTM)
Gross Profit
$21.00K
Operating Income
$36.51M
EBITDA
$36.51M
Operating Cash Flow
$33.33M
Capital Expenditure
$0.00
Free Cash Flow
$33.33M
Cash & ST Invst.
$48.91M
Total Debt
$419.00K
Spruce Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$5.00K
-100.7%
Gross Margin
0.00%
N/A
Market Cap
$81.01M
N/A
Market Cap/Employee
$4.05M
N/A
Employees
20
N/A
Net Income
$14.65M
+37.8%
EBITDA
$12.29M
+47.7%
Quarterly Fundamentals
Net Cash
$48.17M
+33.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$419.00K
-51.3%
Short Term Debt
$317.00K
-83.4%
Return on Assets
-73.49%
N/A
Return on Invested Capital
-85.04%
N/A
Free Cash Flow
$6.46M
+68.8%
Operating Cash Flow
$6.46M
+68.8%